原生T1 mapping诊断慢性心肌梗死患者心肌纤维化的价值
研究前瞻性纳入312例慢性心肌梗死(>6个月)患者和50例无心肌梗死对照,于3.0T行原生T1 mapping与延迟增强成像。结果显示,原生T1 mapping检测慢性心肌梗死的敏感度在存在脂肪化生的患者中为85.6%,显著高于无脂肪化生患者的13.3%,两者特异度相近(100% vs 98.9%)。作者结论认为原生T1 mapping检测替代性纤维化能力差,但若合并脂肪化生可间接检测慢性心肌梗死,用于诊断和表征心肌纤维化不可靠。
要点
- 原生T1 mapping检测慢性心肌梗死的敏感度在脂肪化生患者中为85.6%,显著高于无脂肪化生患者的13.3%。
- 存在脂肪化生时,T1升高区域大小显著低估梗死面积,且与脂肪化生大小的相关性(r=0.76)优于与梗死面积的相关性(r=0.49)。
- 无脂肪化生患者中,T1轻度升高多继发于6至12个月的亚慢性梗死;梗死>12个月者的T1与未梗死心肌无差异。
核心结论
- 原生T1 mapping检测替代性纤维化能力差,若合并脂肪化生可间接检测慢性心肌梗死,用于诊断和表征心肌纤维化不可靠。
研究设计与样本
- 前瞻性研究,连续纳入312例确诊慢性心肌梗死(>6个月)患者和50例无心肌梗死对照,于3.0T行改良Look-Locker反转恢复序列原生T1 mapping和延迟增强成像,脂肪化生采用去相位稳态自由进动电影序列判定并经标准脂肪-水Dixon法验证。
关键影像表现/征象
- 原生T1升高区域以平均值+5SD定量确定,梗死区域在延迟增强图像上定量确定。
- 存在脂肪化生时,T1升高区域大小显著低估梗死面积,且与脂肪化生大小的相关性(r=0.76)优于与梗死面积的相关性(r=0.49)。
- 无脂肪化生患者中,T1轻度升高多继发于6至12个月的亚慢性梗死;梗死>12个月者的T1与未梗死心肌无差异。
诊断标准与关键数值
- 原生T1 mapping检测慢性心肌梗死的敏感度在脂肪化生患者中为85.6%,在无脂肪化生患者中为13.3%;特异度分别为100%和98.9%。
- T1升高区域定义为平均值+5SD。
临床应用与阅片要点
- 阅片时需注意心肌内脂肪可影响原生T1 mapping对慢性心肌梗死的检测准确性。
- 原生T1 mapping检测替代性纤维化不可靠,存在脂肪化生时可间接提示慢性心肌梗死。
- 无脂肪化生时,原生T1 mapping对慢性心肌梗死的检测敏感度低。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Myocardial fibrosis is a fundamental process in cardiac injury. Cardiac magnetic resonance native T1 mapping has been proposed for diagnosing myocardial fibrosis without the need for gadolinium contrast. However, recent studies suggest that T1 measurements can be erroneous in the presence of intramyocardial fat.
OBJECTIVES: The purpose of this study was to investigate whether the presence of fatty metaplasia affects the accuracy of native T1 maps for the diagnosis of myocardial replacement fibrosis in patients with chronic myocardial infarction (MI).
METHODS: Consecutive patients (n = 312) with documented chronic MI (>6 months old) and controls without MI (n = 50) were prospectively enrolled. Presence and size of regions with elevated native T1 and infarction were quantitatively determined (mean + 5SD) on modified look-locker inversion-recovery and delayed-enhancement images, respectively, at 3.0-T. The presence of fatty metaplasia was determined using an out-of-phase steady-state free-precession cine technique and further verified with standard fat-water Dixon methods.
RESULTS: Native T1 mapping detected chronic MI with markedly higher sensitivity in patients with fatty metaplasia than those without fatty metaplasia (85.6% vs 13.3%) with similar specificity (100% vs 98.9%). In patients with fatty metaplasia, the size of regions with elevated T1 significantly underestimated infarct size and there was a better correlation with fatty metaplasia size than infarct size (r = 0.76 vs r = 0.49). In patients without fatty metaplasia, most of the modest elevation in T1 appeared to be secondary to subchronic infarcts that were 6 to 12 months old; the T1 of infarcts >12 months old was not different from noninfarcted myocardium.
CONCLUSIONS: Native T1 mapping is poor at detecting replacement fibrosis but may indirectly detect chronic MI if there is associated fatty metaplasia. Native T1 mapping for the diagnosis and characterization of myocardial fibrosis is unreliable.
引用
- Kaolawanich Y, Azevedo CF, Kim HW, et al. Native T1 Mapping for the Diagnosis of Myocardial Fibrosis in Patients With Chronic Myocardial Infarction. JACC Cardiovasc Imaging. 2022. PMID: 36481075. doi:10.1016/j.jcmg.2022.09.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。